Zhang Jian, Li Quan-Rui, Cui Jing, Fu Xiao-Kang, Tian Geng
Infectious Diseases Department, Capital Medical University XuanWu Hospital, Beijing, 100053, China.
Infectious Diseases Department, Capital Medical University XuanWu Hospital, Beijing, 100053, China.
Free Radic Biol Med. 2025 Sep;237:473-490. doi: 10.1016/j.freeradbiomed.2025.05.434. Epub 2025 Jun 5.
Sepsis-related acute lung injury (ALI) is a severe and life-threatening complication characterized by excessive inflammation and immune dysfunction. Macrophages play a central role in the pathogenesis of ALI, with dysregulated polarization and impaired phagocytic function contributing to disease progression. This study investigates the role of the Specificity Protein 1 (SP1)/Prohibitin 1 (PHB1) axis in regulating macrophage polarization and function in sepsis-associated ALI. Using a cecal ligation and puncture (CLP)-induced mouse model, combined with single-cell RNA sequencing (scRNA-seq), high-throughput sequencing (HTS), and machine learning (ML) algorithms, we identified SP1 and PHB1 as key regulators of ALI. Functional assays demonstrated that SP1 transcriptionally suppresses PHB1 expression, promoting M1 macrophage polarization while impairing phagocytic function, thereby exacerbating sepsis-induced ALI. Immunofluorescence, enzyme-linked immunosorbent assay (ELISA), quantitative polymerase chain reaction (RT-qPCR), and Western blot analyses further validated these findings. In vivo and in vitro studies confirmed that overexpression of SP1 significantly increased lung inflammation, fibrosis, and apoptosis, whereas PHB1 overexpression reversed these pathological effects. The SP1/PHB1 axis was found to modulate macrophage-mediated immune responses through inflammatory cytokine secretion, mitochondrial dysfunction, and oxidative stress. These findings provide novel insights into the molecular mechanisms underlying sepsis-induced ALI and highlight the potential of targeting the SP1/PHB1 axis for therapeutic intervention. Future research should explore targeted therapies aimed at modulating macrophage polarization and improving immune homeostasis in sepsis-associated ALI.
脓毒症相关急性肺损伤(ALI)是一种严重且危及生命的并发症,其特征为过度炎症反应和免疫功能障碍。巨噬细胞在ALI的发病机制中起核心作用,极化失调和吞噬功能受损促进疾病进展。本研究调查特异性蛋白1(SP1)/抑制素1(PHB1)轴在脓毒症相关性ALI中调节巨噬细胞极化和功能的作用。利用盲肠结扎穿孔(CLP)诱导的小鼠模型,结合单细胞RNA测序(scRNA-seq)、高通量测序(HTS)和机器学习(ML)算法,我们确定SP1和PHB1为ALI的关键调节因子。功能试验表明,SP1转录抑制PHB1表达,促进M1巨噬细胞极化,同时损害吞噬功能,从而加剧脓毒症诱导的ALI。免疫荧光、酶联免疫吸附测定(ELISA)、定量聚合酶链反应(RT-qPCR)和蛋白质印迹分析进一步验证了这些发现。体内和体外研究证实,SP1过表达显著增加肺部炎症、纤维化和细胞凋亡,而PHB1过表达可逆转这些病理效应。发现SP1/PHB1轴通过炎症细胞因子分泌、线粒体功能障碍和氧化应激调节巨噬细胞介导的免疫反应。这些发现为脓毒症诱导的ALI的分子机制提供了新见解,并突出了靶向SP1/PHB1轴进行治疗干预的潜力。未来的研究应探索旨在调节巨噬细胞极化和改善脓毒症相关性ALI中免疫稳态的靶向治疗方法。